Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas including articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries. Gut is an official journal of the British Society of Gastroenterology, subscribers to Gut also receive Frontline Gastroenterology .

LATEST ARTICLES

  • Correction: Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
  • Porcine-derived pancreatic enzyme replacement therapy linking to chronic hepatitis E: broad implications
  • Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease
  • Patient-derived organoid biobank identifies epigenetic dysregulation of intestinal epithelial MHC-I as a novel mechanism in severe Crohn’s Disease
  • PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma